Advertisement

Topics

Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

13:00 EDT 1 Oct 2018 | 3blmedia - Health

SOURCE: Gilead Sciences

DESCRIPTION:

Last year, in partnership with Mastercard and the World Hepatitis Alliance, we launched a pilot program in Pakistan to simplify the delivery of HCV treatment in a resource-limited setting with high disease burden.

Learn more in the video above.

Tweet me: Last year, @GileadSciences partnered with @MastercardNews and @Hep_Alliance to simplify delivery of #HCV treatment. Video here: http://bit.ly/2Nh4PSe #healthcare #accesstomedicine #CSR

KEYWORDS: Gilead, mastercard, World Hepatitis Alliance, Pakistan, HCV

Original Article: Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

NEXT ARTICLE

More From BioPortfolio on "Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...